2016 Fiscal Year Final Research Report
Investigation of the effects of autologous bone marrow and spleen cells on pulmonary fibrosis
Project/Area Number |
26461201
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Respiratory organ internal medicine
|
Research Institution | Nippon Medical School |
Principal Investigator |
|
Research Collaborator |
MATSUDA Kuniko 日本医科大学, 実験助手
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Keywords | 制御性T細胞 / 特発性肺線維症 / ブレオマイシン / FGF9 / IL-10 |
Outline of Final Research Achievements |
In the current study, we aimed at the resolution of pulmonary fibrosis using autologous bone marrow or spleen cells. Pulmonary fibrosis was induced by bleomycin (BLM) (day 0), then, bone marrow cells or spleen cells were adoptively transferred via tail veins on day 7 or 14. Adoptive transfer of spleen cells significantly ameliorated BLM-induced murine pulmonary fibrosis on day14. This effect was abrogated by neutralization of CD25 by anti-CD25 monoclonal antibody, which suggests that regulatory T cells (Tregs) are involved in the effect of spleen cells. To further characterize the mechanisms by which Tregs exert anti-fibrotic effects, we isolated Tregs from spleens of C57BL/6 mice using magnetic beads, then, adoptively transferred them into BLM-induced pulmonary fibrosis mice on day 14. Tregs significantly ameliorated pulmonary fibrosis which was measured by Ashcroft score and hydroxyproline. This was accompanied by reduced expression of fibroblast growth factor 9 and IL-10.
|
Free Research Field |
呼吸器内科学
|